COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03437382
Recruitment Status : Recruiting
First Posted : February 19, 2018
Last Update Posted : October 1, 2019
ZonMw: The Netherlands Organisation for Health Research and Development
Health Holland
Quirem Medical B.V.
Maag Lever Darm Stichting
Information provided by (Responsible Party):
MCBurgmans, Leiden University Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 1, 2020
Estimated Study Completion Date : December 1, 2021